Beta Bionics Inc (BBNX) Institutional Holdings & 13F Data (Q2 2026)

BBNX ranks #3837 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

BBNX is a top-conviction position for Pura Vida Investments, LLC — at 11.9% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in BBNX belongs to Eventide Asset Management, LLC, but the position matters far more to Pura Vida Investments, LLC, who has 11.9% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Balyasny Asset Management L.p. has added to its BBNX position for two straight quarters, increasing it by $10.8M to reach $13.4M today.

Farallon Capital Management, L.l.c. has trimmed its BBNX position for two straight quarters, cutting it by $122.1M while still holding $9.3M.

BBNX is up 1.8% today, and institutions have been net buyers of $5.2M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

BBNX reported a net loss of $73.0M over the trailing twelve months.

• Not yet profitable — net loss of $73.0M over the trailing twelve months
• Revenue grew 52.5% year over year
• Net income improved year over year, from -$73.4M to -$73.0M
• Operating cash flow was negative, using $50.9M in cash
• Current ratio of 8.66x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.14x equity — within a conventional range